Sökning: WFRF:(Rydén Per)
> (2020-2024) >
Antiphospholipid an...
Antiphospholipid antibodies in patients with dysglycaemia : A neglected cardiovascular risk factor?
-
- Ferrannini, Giulia (författare)
- Karolinska Institutet
-
- Svenungsson, Elisabet (författare)
- Karolinska Institutet
-
- Kjellstrom, Barbro (författare)
- Karolinska Institutet
-
visa fler...
-
- Elvin, Kerstin (författare)
- Karolinska Institutet
-
- Grosso, Giorgia (författare)
- Karolinska Institutet
-
- Näsman, Per, Docent, 1954- (författare)
- KTH,Fastighetsekonomi och finans
-
- Ryden, Lars (författare)
- Karolinska Institutet
-
- Norhammar, Anna (författare)
- Karolinska Institutet
-
visa färre...
-
(creator_code:org_t)
- 2020-06-07
- 2020
- Engelska.
-
Ingår i: Diabetes & Vascular Disease Research. - : SAGE PUBLICATIONS LTD. - 1479-1641 .- 1752-8984. ; 17:3
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://journals.sag...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: Cardiovascular disease is a serious complication in patients with dysglycaemia, defined as either type 2 diabetes or impaired glucose tolerance. Research focusing on the identification of potential markers for atherothrombotic disease in these subjects is warranted. The antiphospholipid syndrome is a common acquired prothrombotic condition, defined by a combination of thrombotic events and/or obstetric morbidity and positivity of specific antiphospholipid antibodies. Available information on antiphospholipid antibodies in dysglycaemia is scarce. Objective: This study investigates the association between antiphospholipid antibodies and dysglycaemia. Patients/Methods: The PAROKRANK (periodontitis and its relation to coronary artery disease) study included 805 patients, investigated 6-10 weeks after a first myocardial infarction, and 805 matched controls. Participants without known diabetes (91%) underwent an oral glucose tolerance test. Associations between antiphospholipid antibodies (anti-cardiolipin and anti-beta 2 glycoprotein-I IgG, IgM and IgA) and dysglycaemia were analysed. Results: In total, 137 (9%) subjects had previously known type 2 diabetes and 371 (23%) newly diagnosed dysglycaemia. Compared with the normoglycaemic participants, those with dysglycaemia had a higher proportion with first myocardial infarction (61% vs 45%,p < 0.0001) and were more often antiphospholipid antibody IgG positive (8% vs 5%;p = 0.013). HbA1c, fasting glucose and 2-h glucose were significantly associated to antiphospholipid antibody IgG. Odds ratios (ORs) were 1.04 (95% confidence interval [CI] 1.02-1.06), 1.14 (95% CI 1.00 - 1.27) and 1.12 (95% CI 1.04 - 1.21), respectively, after adjustments for age, gender and smoking. Conclusions: This study reports an association between antiphospholipid antibody IgG positivity and dysglycaemia. Further studies are needed to verify these findings and to investigate if antithrombotic therapy reduces vascular complications in antiphospholipid antibody positive subjects with dysglycaemia.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Nyckelord
- Antiphospholipid antibodies
- antithrombotic agents
- diabetes mellitus
- myocardial infarction
- glucose tolerance test
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas